Tranexamic acid and Melphalan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tranexamic acid (tranexamic acid) and Melphalan (melphalan). Common drug interactions include hypertension among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Tranexamic acid and Melphalan. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.
What is Tranexamic acid?
Tranexamic acid has active ingredients of tranexamic acid. It is often used in heavy or prolong menstrual bleeding. eHealthMe is studying from 8,687 Tranexamic acid users. Check the latest studies of Tranexamic acid.
What is Melphalan?
Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.
33 people who take Tranexamic acid and Melphalan together, and have interactions are studied.

What are the common drug interactions of Tranexamic Acid and Melphalan, by gender? *:
female:
- Hypertension (high blood pressure)
- Blood lactate dehydrogenase increased
- Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
- Lung disorder (lung disease)
- Renal failure (kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Retinopathy (acute damage to the retina of the eye)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Respiratory rate increased (excess breathing rate/min)
male:
- Febrile neutropenia (fever with reduced white blood cells)
- Body temperature increased
- Mucosal inflammation (infection of mucous membrane)
- Pain
- Rectal haemorrhage (bleeding from anus)
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
What are the common drug interactions of Tranexamic Acid and Melphalan, by age (0-1 to 60+)? *:
0-1:
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Bone marrow failure
- Febrile neutropenia (fever with reduced white blood cells)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Mucosal inflammation (infection of mucous membrane)
- Pain
- Rectal haemorrhage (bleeding from anus)
2-9:
- Bk virus infection
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Cystitis haemorrhagic (blood in the urine and painful voiding)
- Thrombocytopenia (decrease of platelets in blood)
- Haemoglobin decreased
- Haemorrhage (bleeding)
- Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Brain stem haemorrhage (bleeding into structures of brain stem)
- Disease progression
10-19:
- Blood lactate dehydrogenase increased
- Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
- Hypertension (high blood pressure)
- Lung disorder (lung disease)
- Renal failure (kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Retinopathy (acute damage to the retina of the eye)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
20-29:
n/a
30-39:
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
40-49:
- Body temperature increased
- Diarrhoea
- Escherichia infection (bacterial infection by escherichia coli)
- Febrile neutropenia (fever with reduced white blood cells)
- Frequent bowel movements
- Hypotension (abnormally low blood pressure)
- Leukopenia (less number of white blood cells in blood)
- Pyrexia (fever)
50-59:
- Bradycardia (abnormally slow heart action)
- Chest discomfort
- Respiratory rate increased (excess breathing rate/min)
- Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
60+:
- Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Rash
- Respiratory rate increased (excess breathing rate/min)
- Anxiety
- Body temperature increased
- Chills (felling of cold)
- Hypersensitivity
- Hypertension (high blood pressure)
- Neck pain
What are the existing conditions these people have? *
- Neuroblastoma (a cancer that forms in your nerve tissue): 15 people, 45.45%
- Haemorrhage (bleeding): 12 people, 36.36%
- Bone Marrow Conditioning Regimen: 11 people, 33.33%
- Adverse Event: 5 people, 15.15%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 9.09%
- Stress And Anxiety: 2 people, 6.06%
- Pain: 2 people, 6.06%
- Ovarian Cancer (cancer of ovary): 2 people, 6.06%
- Leukaemia (blood or bone marrow cancer): 2 people, 6.06%
- Insomnia (sleeplessness): 2 people, 6.06%
* Approximation only. Some reports may have incomplete information.
Do you take Tranexamic acid and Melphalan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Tranexamic acid (8,687 reports)
- Melphalan (20,052 reports)
Browse all drug interactions of Tranexamic acid and Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tranexamic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tranexamic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Melphalan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on tranexamic acid and melphalan (the active ingredients of Tranexamic acid and Melphalan, respectively), and Tranexamic acid and Melphalan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Clofarabine cause Pain Exacerbated? - 14 seconds ago
- Drug interactions of Mucinex Dm and Bactrim - 29 seconds ago
- Drug interactions of Ropivacaine Hydrochloride and Epinephrine - 38 seconds ago
- Could Doxycycline Hyclate cause Melanocytic Naevus? - 38 seconds ago
- Could Levothyroxine Sodium cause Optic Nerve Injury? - 43 seconds ago
- Drug interactions of Clopidogrel and Bricanyl - 49 seconds ago
- Could Nasonex cause Medical Device Complication? - 49 seconds ago
- Idiopathic Pulmonary Fibrosis and Failure To Thrive - 49 seconds ago
- Could Invega Sustenna cause Injection Site Pain? - 52 seconds ago
- Could Asa cause Dementia Alzheimer'S Type? - 55 seconds ago